Assignment

Vinge has advised Pandox in connection with a directed share issue

March 30, 2017

Vinge has advised Pandox Aktiebolag (publ) in connection with a directed share issue of 7,499,99 class B shares at a subscription price of SEK 135 per share. Through the share issue, Pandox will obtain approximately SEK 1,012 million. The subscription price was determined through an accelerated book-building process. The share issue is directed to selected Swedish and international institutional investors. The purpose of the share issue is to, in a timely and cost efficient manner, enable a capital raising to finance acquisitions and thereby increase the company’s financial flexibility and mandate for continued value creation.
 
Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. The company’s shares are admitted to trading on Nasdaq Stockholm.
 
Vinge’s team primarily consisted of Jesper Schönbeck, Erik Sjöman, Nils Fredrik Dehlin, Tora Hansjons and Michaela Cronemyr.

Related

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB
April 24, 2025

Vinge advises Biotage in connection with RWK Bidco’s public tender

On 22 April 2025, RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the shareholders in Biotage AB to tender all ordinary shares in Biotage to RWK Bidco at a price of SEK 145 in cash per ordinary share.
April 22, 2025

Vinge advises Baseload Capital in connection with an investment from Google

Vinge has advised Baseload Capital Holding AB in connection with securing an investment from Google.
April 16, 2025